View in EDS HTML Full Text PDF Full Text

A Multicenter, Retrospective Study (RE-ENACT 2) on Razumab™ (World's First Biosimilar Ranibizumab) in Retinal Vein Occlusion.

Saved in:
Bibliographic Details
Title: A Multicenter, Retrospective Study (RE-ENACT 2) on Razumab™ (World's First Biosimilar Ranibizumab) in Retinal Vein Occlusion.
Authors: Sharma, Shashikant1 (AUTHOR) shashikant_sharma@intaspharma.com, RE-ENACT 2 Study Investigators Group (AUTHOR), Anandkumar, Manjunath Bhaskar1 (AUTHOR), Jain, Sangita1 (AUTHOR), Murthy, Hemanth1 (AUTHOR), Murlidhar, Naveenam Srinivasa1 (AUTHOR), Hirawat, Raj Shri1 (AUTHOR), Sudhalkar, Aditya1 (AUTHOR), Deka, Amarendra1 (AUTHOR), Banker, Alay1 (AUTHOR), Parikh, Vatsal1 (AUTHOR), Agarwal, Manisha1 (AUTHOR), Mithal, Charu1 (AUTHOR), Singh, Rajender Pal1 (AUTHOR), Kulkarni, Deepti1 (AUTHOR), Desai, Abhishek1 (AUTHOR), Naigaonkar, Rushikesh1 (AUTHOR), Borse, Nishikant1 (AUTHOR), Saikia, Simanta Pradeep1 (AUTHOR), Sahu, Atul Kumar1 (AUTHOR)
Source: Ophthalmology & Therapy. Sep2020, Vol. 9 Issue 3, p625-639. 15p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:21938245
DOI:10.1007/s40123-020-00277-3